Clinical trial
ATAQ EASY: Artesunate + Amodiaquine Fixed Dose Combination in the Treatment of…
NCT00316329 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00316329 |
|---|---|
| Title | ATAQ EASY: Artesunate + Amodiaquine Fixed Dose Combination in the Treatment of Uncomplicated Plasmodium Falciparum Malaria |
| Official title | Multinational, Randomized, Comparative Study of the Efficacy and Safety of Three Therapeutic Regimens: Coarsucam™ (Artesunate + Amodiaquine Fixed-Dose Combination) Administered in 1 or 2 Intakes Per Day Versus Coartem® (Artemether + Lumefantrine) in the Treatment of Uncomplicated Plasmodium… |
| Lead sponsor | Sanofi, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Malaria |
| Intervention type | Drug |
| Interventions | Artesunate + Amodiaquine |
| Enrollment | 1,032 |
| Start date | Mar 1, 2006 |
| First posted | Apr 20, 2006 |
| Last update posted | Apr 22, 2008 |
| Countries | Cameroon, Madagascar, Mali, Senegal |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: